Weight Loss News and Research

Latest Weight Loss News and Research

Myths and misconceptions about diabetes

November is designated American Diabetes Month and while raising awareness this month about preventing diabetes is important, focusing on proper treatment is just as important for those living with the disease.

15 Oct 2011

QUT program assists cancer survivors in self-managing their health, emotional concerns

The Queensland University of Technology (QUT ) School of Nursing and Midwifery, in Brisbane, Australia, has designed a program to assist cancer survivors in self-managing their health and emotional concerns.

15 Oct 2011

Do weight-loss incentive programs actually work?

Such experiments live at the nexus of cost-benefit analysis, behavioral psychology and the obesity crisis. The best programs are carefully calculated to exploit human nature: our love of a windfall, the risk of losing a small but significant financial stake, the camaraderie of a team effort, the heat of competition. All in the hope it may push us to do something difficult and unpleasant: shed pounds.

12 Oct 2011

Activating brown adipose tissue may help combat obesity, type 2 diabetes

Activating a specialized type of fat, known as brown adipose tissue, may help combat obesity as well as result in better glucose control for type 2 diabetes, according to new research conducted by scientists at the UC Metabolic Diseases Institute.

12 Oct 2011

Over 6,000 Australians joined ‘Weigh it Up Australia’

Weigh it Up Australia re-launched its FREE online healthy living program last Sunday with more than 6,000 Australians signing up to join the program within the first three days. Weigh it Up’s new website offers new and existing members access to more experts and 2 new ways to participate in its healthy living program.

11 Oct 2011

DARA BioSciences' KRN5500 reduces neuropathic pain in patients with cancer

DARA BioSciences, Inc. today announced the Journal of Pain and Symptom Management, an internationally respected, peer-reviewed journal, has published results of a Phase II safety and efficacy study of KRN5500 for the treatment of neuropathic pain in patients with cancer.

11 Oct 2011

Overweight and blood pressure risk in kids: Study

According to a new study kids who are overweight are nearly three times more likely to have high blood pressure compared to their peers. The study, published in the journal Hypertension, followed 1,111 school-aged children in Indiana for an average of four years.

5 Oct 2011

New research relates role of gender and weight management in overall sleep patterns

The benefits of a good night's sleep to overall health have long been reported. Now, new research has emerged relating to the role gender and weight management play in overall sleep patterns. The abstract, Gender Differences in a Naturalistic Observational Study of Sleep and BMI, was presented during a poster session at the annual Obesity Society meeting in Orlando, Florida this week.

4 Oct 2011

Orexigen presents data from Contrave trial at 29th Annual Scientific Meeting of The Obesity Society

Orexigen Therapeutics, Inc., today announced that Contrave (naltrexone SR/bupropion SR) data will be presented in one oral and multiple poster presentations at the 29th Annual Scientific Meeting of The Obesity Society on October 3, 2011 in Orlando, FL.

4 Oct 2011

Large-scale study on cat intestinal cancer could ultimately benefit humans

A recent, large-scale study on cat intestinal cancer has provided new insight into a common pet disease and its causes; the findings could ultimately benefit humans.

29 Sep 2011

Calif. bill could affect out-patient surgery centers; some Florida public hospitals prosper

Also in news about local hospitals, the Mayo Clinic announces plans to develop a new medical school branch in Arizona and a Minn. hospital is accused of dumping a patient.

29 Sep 2011

First Edition: September 28, 2011

Today's headlines include reports about the costs of employer insurance plans and the final installment of KHN's "Building Ambitions" series about children's hospitals.

28 Sep 2011

Arena, Eisai announce new data from lorcaserin Phase 3 clinical trial program

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that new data analyses from the lorcaserin Phase 3 clinical trial program will be presented in poster sessions at Obesity 2011, the 29th Annual Scientific Meeting of The Obesity Society in Orlando, Florida.

27 Sep 2011

Physical activity improves arthritis symptoms in obese mice

Adding another incentive to exercise, scientists at Duke University Medical Center have found that physical activity improves arthritis symptoms even among obese mice that continue to chow down on a high-fat diet.

27 Sep 2011

Sodium Stibogluconate & Paromomycin combination treatment for Kala azar

East Africa is fighting the worst kala azar outbreak in a decade. Collaboration across the region through the Leishmaniasis East Africa Platform (LEAP) has resulted in the development of a new combination therapy (SSG&PM) which is cheaper and nearly halves the length of treatment from a 30 day course of injections to 17 days.

26 Sep 2011

Janssen Biotech receives FDA approval for Remicade to treat UC in children

The U.S. Food and Drug Administration today approved Remicade (infliximab) to treat moderately to severely active ulcerative colitis (UC) in children older than 6 years who have had inadequate response to conventional therapy.

26 Sep 2011

Ambrx, Bristol-Myers Squibb collaborate for novel biologics to treat heart failure and diabetes

Bristol-Myers Squibb Company and Ambrx, Inc. today announced a collaboration under which Bristol-Myers Squibb will receive exclusive worldwide rights to research, develop and commercialize biologics based on Ambrx's research surrounding the Fibroblast Growth Factor 21 protein, for potential use in treating type 2 diabetes, and the Relaxin hormone, for potential use in treating heart failure.

23 Sep 2011